Carrier priming with CRM197or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: Biophysical and immunochemical interpretation
Glycoconjugate vaccines play an enormous role in preventing infectious diseases. The main carrier proteins used in commercial conjugate vaccines are the non-toxic mutant of diphtheria toxin (CRM197), diphtheria toxoid (DT) and tetanus toxoid (TT). Modern childhood routine vaccination schedules inclu...
Gespeichert in:
Veröffentlicht in: | Vaccine 2015-01, Vol.33 (2), p.314 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 2 |
container_start_page | 314 |
container_title | Vaccine |
container_volume | 33 |
creator | Pecetta, S Lo Surdo, P Tontini, M Proietti, D Zambonelli, C Bottomley, MJ Biagini, M Berti, F Costantino, P Romano, MR |
description | Glycoconjugate vaccines play an enormous role in preventing infectious diseases. The main carrier proteins used in commercial conjugate vaccines are the non-toxic mutant of diphtheria toxin (CRM197), diphtheria toxoid (DT) and tetanus toxoid (TT). Modern childhood routine vaccination schedules include the administration of several vaccines simultaneously or in close sequence, increasing the concern that the repeated exposure to conjugates based on these carrier proteins might interfere with the anti-polysaccharide response. Extending previous observations we show here that priming mice with CRM197or DT does not suppress the response to the carbohydrate moiety of CRM197meningococcal serogroup A (MenA) conjugates, while priming with DT can suppress the response to DT-MenA conjugates. To explain these findings we made use of biophysical and immunochemical techniques applied mainly to MenA conjugates. Differential scanning calorimetry and circular dichroism data revealed that the CRM197structure was altered by the chemical conjugation, while DT and the formaldehyde-treated form of CRM197were less impacted, depending on the degree of glycosylation. Investigating the binding and avidity properties of IgGs induced in mice by non-conjugated carriers, we found that CRM197induced low levels of anti-carrier antibodies, with decreased avidity for its MenA conjugates and poor binding to DT and respective MenA conjugates. In contrast, DT induced high antibody titers able to bind with comparable avidity both the protein and its conjugates but showing very low avidity for CRM197and related conjugates. The low intrinsic immunogenicity of CRM197as compared to DT, the structural modifications induced by glycoconjugation and detoxification processes, resulting in conformational changes in CRM197and DT epitopes with consequent alteration of the antibody recognition and avidity, might explain the different behavior of CRM197and DT in a carrier priming context. |
doi_str_mv | 10.1016/j.vaccine.2014.11.026 |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1645366813</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3557501191</sourcerecordid><originalsourceid>FETCH-proquest_journals_16453668133</originalsourceid><addsrcrecordid>eNqNjM1KxDAUhYMoWH8eQbjgemru9Gc6Lh0UN27EhbshpLftLW0Sk3S0D-U7WoZ5AFeH852PI8QdyhQllg99elBas6F0LTFPEVO5Ls9EgtUmW60LrM5FspB8laP8vBRXIfRSyiLDbSJ-d8p7Jg_O88imhW-OHeze33C7sR5qdl3syLOCaH8s19CpAGrhTUOeTAQendIRrIHFW9o4GduSYc1xBtscqafgSEc-ELTDrK22pp9aFSk8whNb182BtRpAmfr0oDsaj4hNJO88RRXZmhtx0agh0O0pr8X9y_PH7nXlvP2aKMR9bydvlmmPZV5kZVlhlv3P-gNa02uF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1645366813</pqid></control><display><type>article</type><title>Carrier priming with CRM197or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: Biophysical and immunochemical interpretation</title><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Pecetta, S ; Lo Surdo, P ; Tontini, M ; Proietti, D ; Zambonelli, C ; Bottomley, MJ ; Biagini, M ; Berti, F ; Costantino, P ; Romano, MR</creator><creatorcontrib>Pecetta, S ; Lo Surdo, P ; Tontini, M ; Proietti, D ; Zambonelli, C ; Bottomley, MJ ; Biagini, M ; Berti, F ; Costantino, P ; Romano, MR</creatorcontrib><description>Glycoconjugate vaccines play an enormous role in preventing infectious diseases. The main carrier proteins used in commercial conjugate vaccines are the non-toxic mutant of diphtheria toxin (CRM197), diphtheria toxoid (DT) and tetanus toxoid (TT). Modern childhood routine vaccination schedules include the administration of several vaccines simultaneously or in close sequence, increasing the concern that the repeated exposure to conjugates based on these carrier proteins might interfere with the anti-polysaccharide response. Extending previous observations we show here that priming mice with CRM197or DT does not suppress the response to the carbohydrate moiety of CRM197meningococcal serogroup A (MenA) conjugates, while priming with DT can suppress the response to DT-MenA conjugates. To explain these findings we made use of biophysical and immunochemical techniques applied mainly to MenA conjugates. Differential scanning calorimetry and circular dichroism data revealed that the CRM197structure was altered by the chemical conjugation, while DT and the formaldehyde-treated form of CRM197were less impacted, depending on the degree of glycosylation. Investigating the binding and avidity properties of IgGs induced in mice by non-conjugated carriers, we found that CRM197induced low levels of anti-carrier antibodies, with decreased avidity for its MenA conjugates and poor binding to DT and respective MenA conjugates. In contrast, DT induced high antibody titers able to bind with comparable avidity both the protein and its conjugates but showing very low avidity for CRM197and related conjugates. The low intrinsic immunogenicity of CRM197as compared to DT, the structural modifications induced by glycoconjugation and detoxification processes, resulting in conformational changes in CRM197and DT epitopes with consequent alteration of the antibody recognition and avidity, might explain the different behavior of CRM197and DT in a carrier priming context.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2014.11.026</identifier><language>eng</language><publisher>Kidlington: Elsevier Limited</publisher><subject>Calorimetry ; Confidence intervals ; Detoxification ; Diphtheria ; Experiments ; Immunogenicity ; Immunology ; Infectious diseases ; Molecular weight ; Proteins ; Toxins ; Vaccines</subject><ispartof>Vaccine, 2015-01, Vol.33 (2), p.314</ispartof><rights>Copyright Elsevier Limited Jan 3, 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1645366813?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,64384,64388,72240</link.rule.ids></links><search><creatorcontrib>Pecetta, S</creatorcontrib><creatorcontrib>Lo Surdo, P</creatorcontrib><creatorcontrib>Tontini, M</creatorcontrib><creatorcontrib>Proietti, D</creatorcontrib><creatorcontrib>Zambonelli, C</creatorcontrib><creatorcontrib>Bottomley, MJ</creatorcontrib><creatorcontrib>Biagini, M</creatorcontrib><creatorcontrib>Berti, F</creatorcontrib><creatorcontrib>Costantino, P</creatorcontrib><creatorcontrib>Romano, MR</creatorcontrib><title>Carrier priming with CRM197or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: Biophysical and immunochemical interpretation</title><title>Vaccine</title><description>Glycoconjugate vaccines play an enormous role in preventing infectious diseases. The main carrier proteins used in commercial conjugate vaccines are the non-toxic mutant of diphtheria toxin (CRM197), diphtheria toxoid (DT) and tetanus toxoid (TT). Modern childhood routine vaccination schedules include the administration of several vaccines simultaneously or in close sequence, increasing the concern that the repeated exposure to conjugates based on these carrier proteins might interfere with the anti-polysaccharide response. Extending previous observations we show here that priming mice with CRM197or DT does not suppress the response to the carbohydrate moiety of CRM197meningococcal serogroup A (MenA) conjugates, while priming with DT can suppress the response to DT-MenA conjugates. To explain these findings we made use of biophysical and immunochemical techniques applied mainly to MenA conjugates. Differential scanning calorimetry and circular dichroism data revealed that the CRM197structure was altered by the chemical conjugation, while DT and the formaldehyde-treated form of CRM197were less impacted, depending on the degree of glycosylation. Investigating the binding and avidity properties of IgGs induced in mice by non-conjugated carriers, we found that CRM197induced low levels of anti-carrier antibodies, with decreased avidity for its MenA conjugates and poor binding to DT and respective MenA conjugates. In contrast, DT induced high antibody titers able to bind with comparable avidity both the protein and its conjugates but showing very low avidity for CRM197and related conjugates. The low intrinsic immunogenicity of CRM197as compared to DT, the structural modifications induced by glycoconjugation and detoxification processes, resulting in conformational changes in CRM197and DT epitopes with consequent alteration of the antibody recognition and avidity, might explain the different behavior of CRM197and DT in a carrier priming context.</description><subject>Calorimetry</subject><subject>Confidence intervals</subject><subject>Detoxification</subject><subject>Diphtheria</subject><subject>Experiments</subject><subject>Immunogenicity</subject><subject>Immunology</subject><subject>Infectious diseases</subject><subject>Molecular weight</subject><subject>Proteins</subject><subject>Toxins</subject><subject>Vaccines</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNjM1KxDAUhYMoWH8eQbjgemru9Gc6Lh0UN27EhbshpLftLW0Sk3S0D-U7WoZ5AFeH852PI8QdyhQllg99elBas6F0LTFPEVO5Ls9EgtUmW60LrM5FspB8laP8vBRXIfRSyiLDbSJ-d8p7Jg_O88imhW-OHeze33C7sR5qdl3syLOCaH8s19CpAGrhTUOeTAQendIRrIHFW9o4GduSYc1xBtscqafgSEc-ELTDrK22pp9aFSk8whNb182BtRpAmfr0oDsaj4hNJO88RRXZmhtx0agh0O0pr8X9y_PH7nXlvP2aKMR9bydvlmmPZV5kZVlhlv3P-gNa02uF</recordid><startdate>20150103</startdate><enddate>20150103</enddate><creator>Pecetta, S</creator><creator>Lo Surdo, P</creator><creator>Tontini, M</creator><creator>Proietti, D</creator><creator>Zambonelli, C</creator><creator>Bottomley, MJ</creator><creator>Biagini, M</creator><creator>Berti, F</creator><creator>Costantino, P</creator><creator>Romano, MR</creator><general>Elsevier Limited</general><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20150103</creationdate><title>Carrier priming with CRM197or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: Biophysical and immunochemical interpretation</title><author>Pecetta, S ; Lo Surdo, P ; Tontini, M ; Proietti, D ; Zambonelli, C ; Bottomley, MJ ; Biagini, M ; Berti, F ; Costantino, P ; Romano, MR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_16453668133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Calorimetry</topic><topic>Confidence intervals</topic><topic>Detoxification</topic><topic>Diphtheria</topic><topic>Experiments</topic><topic>Immunogenicity</topic><topic>Immunology</topic><topic>Infectious diseases</topic><topic>Molecular weight</topic><topic>Proteins</topic><topic>Toxins</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pecetta, S</creatorcontrib><creatorcontrib>Lo Surdo, P</creatorcontrib><creatorcontrib>Tontini, M</creatorcontrib><creatorcontrib>Proietti, D</creatorcontrib><creatorcontrib>Zambonelli, C</creatorcontrib><creatorcontrib>Bottomley, MJ</creatorcontrib><creatorcontrib>Biagini, M</creatorcontrib><creatorcontrib>Berti, F</creatorcontrib><creatorcontrib>Costantino, P</creatorcontrib><creatorcontrib>Romano, MR</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pecetta, S</au><au>Lo Surdo, P</au><au>Tontini, M</au><au>Proietti, D</au><au>Zambonelli, C</au><au>Bottomley, MJ</au><au>Biagini, M</au><au>Berti, F</au><au>Costantino, P</au><au>Romano, MR</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carrier priming with CRM197or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: Biophysical and immunochemical interpretation</atitle><jtitle>Vaccine</jtitle><date>2015-01-03</date><risdate>2015</risdate><volume>33</volume><issue>2</issue><spage>314</spage><pages>314-</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Glycoconjugate vaccines play an enormous role in preventing infectious diseases. The main carrier proteins used in commercial conjugate vaccines are the non-toxic mutant of diphtheria toxin (CRM197), diphtheria toxoid (DT) and tetanus toxoid (TT). Modern childhood routine vaccination schedules include the administration of several vaccines simultaneously or in close sequence, increasing the concern that the repeated exposure to conjugates based on these carrier proteins might interfere with the anti-polysaccharide response. Extending previous observations we show here that priming mice with CRM197or DT does not suppress the response to the carbohydrate moiety of CRM197meningococcal serogroup A (MenA) conjugates, while priming with DT can suppress the response to DT-MenA conjugates. To explain these findings we made use of biophysical and immunochemical techniques applied mainly to MenA conjugates. Differential scanning calorimetry and circular dichroism data revealed that the CRM197structure was altered by the chemical conjugation, while DT and the formaldehyde-treated form of CRM197were less impacted, depending on the degree of glycosylation. Investigating the binding and avidity properties of IgGs induced in mice by non-conjugated carriers, we found that CRM197induced low levels of anti-carrier antibodies, with decreased avidity for its MenA conjugates and poor binding to DT and respective MenA conjugates. In contrast, DT induced high antibody titers able to bind with comparable avidity both the protein and its conjugates but showing very low avidity for CRM197and related conjugates. The low intrinsic immunogenicity of CRM197as compared to DT, the structural modifications induced by glycoconjugation and detoxification processes, resulting in conformational changes in CRM197and DT epitopes with consequent alteration of the antibody recognition and avidity, might explain the different behavior of CRM197and DT in a carrier priming context.</abstract><cop>Kidlington</cop><pub>Elsevier Limited</pub><doi>10.1016/j.vaccine.2014.11.026</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2015-01, Vol.33 (2), p.314 |
issn | 0264-410X 1873-2518 |
language | eng |
recordid | cdi_proquest_journals_1645366813 |
source | ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland |
subjects | Calorimetry Confidence intervals Detoxification Diphtheria Experiments Immunogenicity Immunology Infectious diseases Molecular weight Proteins Toxins Vaccines |
title | Carrier priming with CRM197or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: Biophysical and immunochemical interpretation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T15%3A25%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carrier%20priming%20with%20CRM197or%20diphtheria%20toxoid%20has%20a%20different%20impact%20on%20the%20immunogenicity%20of%20the%20respective%20glycoconjugates:%20Biophysical%20and%20immunochemical%20interpretation&rft.jtitle=Vaccine&rft.au=Pecetta,%20S&rft.date=2015-01-03&rft.volume=33&rft.issue=2&rft.spage=314&rft.pages=314-&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2014.11.026&rft_dat=%3Cproquest%3E3557501191%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1645366813&rft_id=info:pmid/&rfr_iscdi=true |